PMID- 33274063 OWN - NLM STAT- MEDLINE DCOM- 20210803 LR - 20240501 IS - 2047-2986 (Electronic) IS - 2047-2978 (Print) IS - 2047-2978 (Linking) VI - 10 IP - 2 DP - 2020 Dec TI - HIV-related stigma trends in the general population of India during an era of antiretroviral treatment expansion, 2005-16. PG - 020420 LID - 10.7189/jogh.10.020420 [doi] LID - 020420 AB - BACKGROUND: In India, which has the world's third-largest HIV epidemic, the extent to which levels of HIV-related stigma have changed during an era of ART scale-up is unknown. METHODS: We analyzed data from the 2005-06 and 2015-16 National Family Health Surveys (NFHS) to estimate trends in two stigma domains among people in the general population: desires for social distance from people living with HIV (ie, unwillingness to interact) and fear of serostatus disclosure in the case of a hypothetical HIV infection. We fitted multivariable linear probability models to the data with year of NFHS as the explanatory variable and alternately specifying fear of disclosure or desires for social distance as the dependent variable. Analyses were stratified by sex, state, and high vs low HIV prevalence states. RESULTS: We included data on 172 795 women and 159 194 men. Desires for social distance declined in 2015-16 compared with 2005-06 (38% in 2015-16 vs 43% in 2005-06; adjusted b = -0.046; 95% confidence interval (CI = -0.049 to -0.043; P < 0.001) but fear of serostatus disclosure increased (31% in 2005-06 vs 37% in 2015-16; adjusted b = 0.058; 95% CI = 0.055-0.062; P < 0.001). Declines in social distancing were more pronounced among men and in high HIV prevalence states. Increased fear of serostatus disclosure was greater among women and in high HIV prevalence states. There was significant variability in trends disaggregated by state. CONCLUSIONS: During the first decade of ART scale-up in India, fear of HIV serostatus disclosure in the general population increased despite a decline in desires for social distance. CI - Copyright (c) 2020 by the Journal of Global Health. All rights reserved. FAU - Chan, Brian T AU - Chan BT AD - Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA. AD - Harvard Medical School, Boston, Massachusetts, USA. FAU - Chakrapani, Venkatesan AU - Chakrapani V AD - Centre for Sexuality and Health Research and Policy (C-SHaRP), Chennai, India. AD - The Humsafar Trust, Mumbai, India. FAU - Tsai, Alexander C AU - Tsai AC AD - Harvard Medical School, Boston, Massachusetts, USA. AD - Chester M. Pierce, MD Division of Global Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA. AD - Mbarara University of Science and Technology, Mbarara, Uganda. LA - eng GR - WT_/Wellcome Trust/United Kingdom GR - K23 MH110338/MH/NIMH NIH HHS/United States PT - Journal Article PL - Scotland TA - J Glob Health JT - Journal of global health JID - 101578780 RN - 0 (Anti-Retroviral Agents) SB - IM MH - Adult MH - Anti-Retroviral Agents/therapeutic use MH - Disclosure MH - Female MH - *HIV Infections/drug therapy MH - Humans MH - India MH - Male MH - *Social Stigma MH - Surveys and Questionnaires MH - Young Adult PMC - PMC7698569 COIS- Competing interests: The authors completed the ICMJE Unified Competing Interest form (available upon request from the corresponding author) and declare no conflicts of interest. EDAT- 2020/12/05 06:00 MHDA- 2021/08/04 06:00 PMCR- 2020/09/23 CRDT- 2020/12/04 05:47 PHST- 2020/12/04 05:47 [entrez] PHST- 2020/12/05 06:00 [pubmed] PHST- 2021/08/04 06:00 [medline] PHST- 2020/09/23 00:00 [pmc-release] AID - jogh-10-020420 [pii] AID - 10.7189/jogh.10.020420 [doi] PST - ppublish SO - J Glob Health. 2020 Dec;10(2):020420. doi: 10.7189/jogh.10.020420.